Managing Side Effects The most common side effects reported with GLP-1 medications include nausea, vomiting, fatigue, and gastrointestinal discomfort
Gastrointestinal side effects are the most common early experiences, affecting 3050% of patients to varying degrees
Table of Contents What Determines the Timeline Week 1: Acute GH Response Weeks 2-4: IGF-1 Accumulation Phase Months 1-2: Body Composition Shifts Months 3-6: Long-Term Optimization Factors That Affect Results Results by Use Case Protocol Adjustment Patterns in Community Reports Related Reading References What Determines the Timeline Before the week-by-week breakdown, three variables control how fast results appear: 1
Both GLP-1R and Y1-R are coupled to the G i subunit, in association with reduced levels of cAMP and protein kinase A (PKA) signaling
Dose-finding RCT of diabetic patients (N = 1210) given either GLP1/GIP medication weekly or PC: After 68 weeks, mean weight loss was 10% ( GLP1/GIP medication ), 7% (lower dose GLP1/GIP medication ), and 3% (PC)
Phase 2 trials are primarily designed to assess dose-response relationships and safety signals rather than to definitively establish efficacy at a population level
